Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Hong Kong Centre for Cerebro-Cardiovascular Health Engineering Limited manages a company patent portfolio in the Chemistry & Materials technology area with 1 pending office action. This active case is being reviewed by 1 distinct examiner within 1 distinct art unit. This represents a focused prosecution footprint, where all current patent office activity is directed through a single technical and administrative channel.
The busiest examiner for this portfolio is GERIDO, DWAN A, who is responsible for 1 busiest examiner pending action. Because the total number of pending office actions is 1, this examiner manages the company's entire active workload. The progress of the portfolio in the Chemistry & Materials sector is currently tied to the specific examination results of this 1 pending office action under this examiner's review.
The 1:1 ratio of distinct examiners to pending office actions indicates a lack of diversification in the company's current prosecution efforts. With only 1 distinct art unit involved, the company's legal strategy is subject to the specific trends and timelines of that unit. This concentration on 1 pending office action allows for a dedicated focus on a single matter but provides no alternative paths for patent allowance at this time.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GERIDO, DWAN A | 1 | 58.0% | +30.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17876787 | Method Of Diagnosing Cardiovascular Diseases, And A Device For Separating Components Of A Fluid Sample For Diagnosing Cardiovascular Diseases | GERIDO, DWAN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17876787 | Method Of Diagnosing Cardiovascular Diseases, And A Device For Separating Components Of A Fluid Sample For Diagnosing Cardiovascular Diseases | GERIDO, DWAN A | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17876787 | Method Of Diagnosing Cardiovascular Diseases, And A Device For Separating Components Of A Fluid Sample For Diagnosing Cardiovascular Diseases | GERIDO, DWAN A | 1797 | §101 | Non-Final OA | — | Pending | Jul 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial